Skip to content

Assessment and Rehabilitation of Cognitive Impairments in Pediatric Survivors of Cancer

Assessment and Rehabilitation of Cognitive Impairments in Pediatric Survivors of Cancer

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00490334
Enrollment
72
Registered
2007-06-22
Start date
2007-08-31
Completion date
2012-09-30
Last updated
2015-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neoplasms

Keywords

Carcinomas, Squamous Cel, Adenocarcinoma, Acute Lymphocytic Leukemia

Brief summary

This research involves assessment of cognitive outcome in childhood cancer as well as evaluation of a cognitive rehabilitation program for improving learning and problem solving difficulties in children with cancer.

Detailed description

The purpose of this study is to help determine specific cognitive-behavioral and neurobiologic impairments associated with chemotherapy treatments in children with cancer and to assess the efficacy of a cognitive intervention program for improving cognitive impairments in these children.

Interventions

None listed

Sponsors

Stanford University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
9 Years to 16 Years
Healthy volunteers
Yes

Inclusion criteria

INCLUSION Everyone: * At least 9 years of age and less than 17 years Patients * Diagnosis of brain tumor or acute lymphocytic leukemia (ALL) * Completed all anti-cancer treatment(s) including chemotherapy, radiation and/or surgery Control group * Typical for age EXCLUSION Everyone: * Non-English speaking (translated cognitive testing and MRI assessments unavailable) * MRI contraindication, including but not limited to orthodontia, metal implants, and/or pacemaker * Major sensory deficit disorders, including but not limited to blindness or deafness Patients * Shunt placement * Received bone marrow transplant * History of neurologic, psychiatric, developmental or major medical condition (eg, diabetes) NOT related to cancer * Participation in any concurrent cognitive rehabilitation study Control group * History of neurologic, psychiatric, developmental or major medical condition (eg, diabetes)

Design outcomes

Primary

MeasureTime frame
Performance on neuropsychological testing and brain activation patterns measured by functional MRI8 weeks

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026